PortfoliosLab logoPortfoliosLab logo
LFST vs. CME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LFST vs. CME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LifeStance Health Group, Inc. (LFST) and CME Group Inc. (CME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LFST achieves a 6.53% return, which is significantly higher than CME's -5.27% return.


LFST

1D
-3.35%
1M
3.16%
YTD
6.53%
6M
17.19%
1Y
25.84%
3Y*
-3.94%
5Y*
10Y*

CME

1D
0.84%
1M
-12.97%
YTD
-5.27%
6M
-5.27%
1Y
-7.08%
3Y*
15.77%
5Y*
7.35%
10Y*
14.41%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LFST vs. CME - Yearly Performance Comparison


2026 (YTD)20252024202320222021
LFST
LifeStance Health Group, Inc.
6.53%-4.48%-5.87%58.50%-48.11%-56.53%
CME
CME Group Inc.
-5.27%19.83%15.41%31.32%-22.89%9.80%

Correlation

The correlation between LFST and CME is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

-0.01

Correlation (All Time)
Calculated using the full available price history since Jun 11, 2021

0.08

The correlation between LFST and CME shifts across timeframes, from -0.04 (1 year) to 0.08 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

LFST:

$2.96B

CME:

$91.76B

EPS

LFST:

$0.06

CME:

$11.75

PE Ratio

LFST:

126.10

CME:

21.50

PEG Ratio

LFST:

1.30

CME:

1.88

PS Ratio

LFST:

1.96

CME:

13.50

PB Ratio

LFST:

2.01

CME:

3.45

Total Revenue (TTM)

LFST:

$1.49B

CME:

$6.76B

Gross Profit (TTM)

LFST:

$323.87M

CME:

$5.84B

EBITDA (TTM)

LFST:

$83.67M

CME:

$5.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LFST vs. CME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LFST
LFST Risk / Return Rank: 5959
Overall Rank
LFST Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
LFST Sortino Ratio Rank: 6060
Sortino Ratio Rank
LFST Omega Ratio Rank: 5959
Omega Ratio Rank
LFST Calmar Ratio Rank: 5656
Calmar Ratio Rank
LFST Martin Ratio Rank: 6060
Martin Ratio Rank

CME
CME Risk / Return Rank: 2323
Overall Rank
CME Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
CME Sortino Ratio Rank: 2222
Sortino Ratio Rank
CME Omega Ratio Rank: 2222
Omega Ratio Rank
CME Calmar Ratio Rank: 2929
Calmar Ratio Rank
CME Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LFST vs. CME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for LifeStance Health Group, Inc. (LFST) and CME Group Inc. (CME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LFSTCMEDifference

Sharpe ratio

Return per unit of total volatility

0.47

-0.35

+0.82

Sortino ratio

Return per unit of downside risk

1.26

-0.34

+1.60

Omega ratio

Gain probability vs. loss probability

1.16

0.96

+0.20

Calmar ratio

Return relative to maximum drawdown

0.71

-0.33

+1.05

Martin ratio

Return relative to average drawdown

1.99

-1.19

+3.17

LFST vs. CME - Sharpe Ratio Comparison

The current LFST Sharpe Ratio is 0.47, which is higher than the CME Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of LFST and CME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LFSTCMEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.47

-0.35

+0.82

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.37

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.61

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.29

0.59

-0.88

Drawdowns

LFST vs. CME - Drawdown Comparison

The maximum LFST drawdown since its inception was -86.91%, which is greater than CME's maximum drawdown of -77.50%. Use the drawdown chart below to compare losses from any high point for LFST and CME.


Loading charts...

Drawdown Indicators


LFSTCMEDifference

Max Drawdown

Largest peak-to-trough decline

-86.91%

-77.50%

-9.41%

Max Drawdown (1Y)

Largest decline over 1 year

-36.30%

-21.42%

-14.88%

Max Drawdown (3Y)

Largest decline over 3 years

-59.68%

-21.42%

-38.26%

Max Drawdown (5Y)

Largest decline over 5 years

-31.74%

Max Drawdown (10Y)

Largest decline over 10 years

-37.36%

Current Drawdown

Current decline from peak

-74.09%

-20.76%

-53.33%

Average Drawdown

Average peak-to-trough decline

-72.77%

-20.69%

-52.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.11%

6.03%

+7.08%

Volatility

LFST vs. CME - Volatility Comparison

LifeStance Health Group, Inc. (LFST) has a higher volatility of 25.53% compared to CME Group Inc. (CME) at 9.91%. This indicates that LFST's price experiences larger fluctuations and is considered to be riskier than CME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LFSTCMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

25.53%

9.91%

+15.62%

Volatility (6M)

Calculated over the trailing 6-month period

33.02%

16.74%

+16.28%

Volatility (1Y)

Calculated over the trailing 1-year period

55.02%

20.47%

+34.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.44%

20.03%

+47.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

67.44%

23.87%

+43.57%

Dividends

LFST vs. CME - Dividend Comparison

LFST has not paid dividends to shareholders, while CME's dividend yield for the trailing twelve months is around 4.43%.


PositionTTM20252024202320222021202020192018201720162015
CME
CME Group Inc.
4.43%1.83%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%
LFST
LifeStance Health Group, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

LFST vs. CME - Financials Comparison

This section allows you to compare key financial metrics between LifeStance Health Group, Inc. and CME Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20222023202420252026
403.48M
1.88B
(LFST) Total Revenue
(CME) Total Revenue
Values in USD except per share items

LFST vs. CME - Profitability Comparison

The chart below illustrates the profitability comparison between LifeStance Health Group, Inc. and CME Group Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%202220232024202520260
88.1%
Portfolio components
LFST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LifeStance Health Group, Inc. reported a gross profit of 0.00 and revenue of 403.48M. Therefore, the gross margin over that period was 0.0%.

CME - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a gross profit of 1.66B and revenue of 1.88B. Therefore, the gross margin over that period was 88.1%.

LFST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LifeStance Health Group, Inc. reported an operating income of 22.28M and revenue of 403.48M, resulting in an operating margin of 5.5%.

CME - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported an operating income of 1.31B and revenue of 1.88B, resulting in an operating margin of 69.7%.

LFST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LifeStance Health Group, Inc. reported a net income of 14.24M and revenue of 403.48M, resulting in a net margin of 3.5%.

CME - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a net income of 1.15B and revenue of 1.88B, resulting in a net margin of 61.4%.


Frequently Asked Questions


LFST and CME have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LFST has higher volatility (25.53%) compared to CME (9.91%). In terms of maximum drawdown, LFST dropped -86.91% vs CME's -77.50%.

LFST currently has the higher Sharpe Ratio (0.47 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LFST and CME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer